Twist Bioscience Corporation Shares Outstanding
Twist Bioscience Corporation (TWST) had Shares Outstanding of 62.67 million shares as of 2026-06-30, per its 10-Q filed 2026-08-03.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-03
- 2026-06-30: Shares outstanding (split-adjusted) 62.67M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 62.15M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 61.27M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 60.63M shares; Shares authorized (split-adjusted) 200.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 62.67M shares 10-Q · filed 2026-08-03 | 200.00M shares 10-Q · filed 2026-08-03 |
| 2026-03-31 | 62.15M shares 10-Q · filed 2026-05-04 | 200.00M shares 10-Q · filed 2026-05-04 |
| 2025-12-31 | 61.27M shares 10-Q/A · filed 2026-02-26 | 200.00M shares 10-Q/A · filed 2026-02-26 |
| 2025-09-30 | 60.63M shares 10-Q · filed 2026-08-03 | 200.00M shares 10-Q · filed 2026-08-03 |
| 2025-06-30 | 60.17M shares 10-Q · filed 2025-08-04 | 200.00M shares 10-Q · filed 2025-08-04 |
| 2025-03-31 | 59.86M shares 10-Q · filed 2025-05-05 | 200.00M shares 10-Q · filed 2025-05-05 |
| 2025-02-28 | (m) | 200.00M shares 10-K · filed 2025-11-17 |
| 2024-12-31 | 59.58M shares 10-Q · filed 2025-02-03 | 100.00M shares 10-Q · filed 2025-02-03 |
| 2024-09-30 | 58.88M shares 10-K · filed 2025-11-17 | 100.00M shares 10-K · filed 2025-11-17 |
| 2024-06-30 | 58.52M shares 10-Q · filed 2024-08-02 | 100.00M shares 10-Q · filed 2024-08-02 |
| 2024-03-31 | 58.16M shares 10-Q · filed 2024-05-02 | 100.00M shares 10-Q · filed 2024-05-02 |
| 2023-12-31 | 57.78M shares 10-Q · filed 2024-02-02 | 100.00M shares 10-Q · filed 2024-02-02 |
| 2023-09-30 | 57.56M shares 10-K · filed 2024-11-18 | 100.00M shares 10-K · filed 2024-11-18 |
| 2023-06-30 | 57.37M shares 10-Q · filed 2023-08-07 | 100.00M shares 10-Q · filed 2023-08-07 |
| 2023-03-31 | 57.10M shares 10-Q · filed 2023-05-08 | 100.00M shares 10-Q · filed 2023-05-08 |
| 2022-12-31 | 56.65M shares 10-Q · filed 2023-02-07 | 100.00M shares 10-Q · filed 2023-02-07 |
| 2022-09-30 | 56.52M shares 10-K · filed 2023-11-21 | 100.00M shares 10-K · filed 2023-11-21 |
| 2022-06-30 | 56.34M shares 10-Q · filed 2022-08-08 | 100.00M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 56.23M shares 10-Q · filed 2022-05-06 | 100.00M shares 10-Q · filed 2022-05-06 |
| 2021-12-31 | 50.73M shares 10-Q · filed 2022-02-09 | 100.00M shares 10-Q · filed 2022-02-09 |
| 2021-09-30 | 49.50M shares 10-K/A · filed 2023-06-05 | 100.00M shares 10-K/A · filed 2023-06-05 |
| 2021-06-30 | 49.26M shares 10-Q · filed 2021-08-09 | 100.00M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 48.86M shares 10-Q · filed 2021-05-07 | 100.00M shares 10-Q · filed 2021-05-07 |
| 2020-12-31 | 48.62M shares 10-Q · filed 2021-02-09 | 100.00M shares 10-Q · filed 2021-02-09 |
| 2020-09-30 | 45.08M shares 10-K · filed 2021-11-23 | 100.00M shares 10-K · filed 2021-11-23 |
| 2020-06-30 | 44.62M shares 10-Q · filed 2020-08-12 | 100.00M shares 10-Q · filed 2020-08-12 |
| 2020-03-31 | 40.97M shares 10-Q · filed 2020-05-13 | 100.00M shares 10-Q · filed 2020-05-13 |
| 2019-12-31 | 33.26M shares 10-Q · filed 2020-02-10 | 100.00M shares 10-Q · filed 2020-02-10 |
| 2019-09-30 | 32.87M shares 10-K · filed 2020-11-27 | 100.00M shares 10-K · filed 2020-11-27 |
| 2019-06-30 | 32.47M shares 10-Q · filed 2019-08-09 | 100.00M shares 10-Q · filed 2019-08-09 |
| 2019-03-31 | 28.02M shares 10-Q · filed 2019-05-02 | 100.00M shares 10-Q · filed 2019-05-02 |
| 2018-12-31 | 28.01M shares 10-Q · filed 2019-02-11 | 100.00M shares 10-Q · filed 2019-02-11 |
| 2018-09-30 | 3.21M shares 10-K · filed 2019-12-13 | 21.21M shares 10-K · filed 2019-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |